Reumatoloxía

2002

1. Corticotropin releasing hormone promoter polymorphisms in giant cell arteritis and polymyalgia rheumatica

   Clinical and Experimental Rheumatology, Vol. 20, Núm. 2, pp. 133-138

2. Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia

   AIDS, Vol. 16, Núm. 15, pp. 2079-2081

3. Enfermedad de Crohn y dolor en la cadera

   Revista española de reumatología: Órgano Oficial de la Sociedad Española de Reumatología, Vol. 29, Núm. 9, pp. 461-463

4. HLA-B35 association with nephritis in Henoch-Schönlein purpura

   Journal of Rheumatology, Vol. 29, Núm. 5, pp. 948-949

5. Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis exhibit different HLA-DRB1 associations

   Journal of Rheumatology, Vol. 29, Núm. 5, pp. 945-947

6. Henoch-Schönlein purpura in children and adults: Clinical differences in a defined population

   Seminars in Arthritis and Rheumatism, Vol. 32, Núm. 3, pp. 149-156

7. IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis

   Clinical and Experimental Rheumatology, Vol. 20, Núm. 2, pp. 179-184

8. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis

   Seminars in Arthritis and Rheumatism, Vol. 31, Núm. 6, pp. 355-360

9. Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica

   Journal of Rheumatology, Vol. 29, Núm. 3, pp. 502-504

10. Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura

    Journal of Rheumatology, Vol. 29, Núm. 7, pp. 1404-1407

11. Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum

    Journal of Rheumatology, Vol. 29, Núm. 8, pp. 1671-1673

12. Morbimortalidad en la artritis reumatoide

    Seminarios de la Fundacion Espanola de Reumatologia, Vol. 3, Núm. 2, pp. 66-75

13. Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset

    Journal of Rheumatology, Vol. 29, Núm. 2, pp. 271-275

14. Plasma and peripheral leukocyte β-N-acetylhexosaminidase isoenzymes and disease activity in rheumatoid arthritis

    Clinical Biochemistry, Vol. 35, Núm. 6, pp. 483-488

15. SENC (Spanish Efavirenz vs. Nevirapine Comparison) trial: A randomized, open-label study in HIV-infected naive individuals

    HIV Clinical Trials, Vol. 3, Núm. 3, pp. 186-194

16. Systemic vasculitides

    Best Practice and Research: Clinical Rheumatology, Vol. 16, Núm. 5, pp. 833-845

17. The prevalence of rheumatoid arthritis in the general population of Spain

    Rheumatology, Vol. 41, Núm. 1, pp. 88-95

18. Tuberculous spondylitis: Epidemiologic and clinical study in non-HIV patients from Nortwest Spain

    Clinical and Experimental Rheumatology, Vol. 20, Núm. 3, pp. 327-333

19. Tubulointerstitial nephritis and uveitis syndrome in Southern Spain

    Seminars in Arthritis and Rheumatism, Vol. 32, Núm. 2, pp. 125-129